Similar to HER2-targeted therapy in breast cancer (e.g., trastuzumab) (22, 23), Ewing sarcoma has long been known to express high levels of CD99, also known as p30/32MIC2 (24). This evidence concerns the gene CD99 and Ewing sarcoma.